What question did this study set out to answer?

This study aims to evaluate the prevalence and dynamics of mild cognitive impairment in newly diagnosed type 2 diabetes without vascular complications.

July 5, 2026Experimental and Clinical Endocrinology & Diabetes

Mild cognitive impairment in newly diagnosed type 2 diabetes without microvascular or macrovascular complications: Prevalence, dynamics, and clinical predictors

View Full Paper

Ask AI

Bookmark

Authors

ACA CoppolaIstituto Nazionale per le Malattie Infettive Lazzaro Spallanzani CPCarmelo PujiaMagna Graecia University ACAlberto CastagnaMagna Graecia University

Discussion

Member takes

Implication

Randomized trial finds mild cognitive impairment prevalence in newly diagnosed type 2 diabetes, suggesting cognitive health monitoring is crucial.

Key Points

This study aims to evaluate the prevalence and dynamics of mild cognitive impairment in newly diagnosed type 2 diabetes without vascular complications.
Prospective follow-up of 937 adults with newly diagnosed type 2 diabetes for a mean of 62.7 months.
Cognitive status assessed via the Montreal Cognitive Assessment.
Multivariable models identified clinical predictors of cognitive impairment.
30.5% of patients had mild cognitive impairment at baseline.
15.0% of patients with baseline mild cognitive impairment experienced remission during follow-up.
Higher C-peptide levels were associated with prevalent mild cognitive impairment.

Cite This Study

Coppola et al. (2026) studied this question.

synapsesocial.com/papers/6a49f68df5d1d45b28800ea0 https://doi.org/10.1055/a-2893-3900

View Full Paper

Ask AI

Bookmark

Implication

Randomized trial finds mild cognitive impairment prevalence in newly diagnosed type 2 diabetes, suggesting cognitive health monitoring is crucial.

Mild cognitive impairment in newly diagnosed type 2 diabetes without microvascular or macrovascular complications: Prevalence, dynamics, and clinical predictors

Discussion

Member takes

Implication

Key Points

Cite This Study

Mild cognitive impairment in newly diagnosed type 2 diabetes without microvascular or macrovascular complications: Prevalence, dynamics, and clinical predictors

Discussion

Member takes

Implication

Key Points

Cite This Study

Also Consider

Also Consider